SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042834
Filing Date
2021-08-10
Accepted
2021-08-09 21:32:52
Documents
86
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20210630.htm   iXBRL 10-Q 3418007
2 EX-10.1 flgt-ex101_40.htm EX-10.1 264916
3 EX-31.1 flgt-ex311_9.htm EX-31.1 20831
4 EX-31.2 flgt-ex312_7.htm EX-31.2 20821
5 EX-32.1 flgt-ex321_8.htm EX-32.1 18143
  Complete submission text file 0001564590-21-042834.txt   12252083

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flgt-20210630.xsd EX-101.SCH 68284
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20210630_cal.xml EX-101.CAL 92380
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20210630_def.xml EX-101.DEF 214615
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20210630_lab.xml EX-101.LAB 518453
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20210630_pre.xml EX-101.PRE 402655
11 EXTRACTED XBRL INSTANCE DOCUMENT flgt-10q_20210630_htm.xml XML 2519931
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 211158177
SIC: 8071 Services-Medical Laboratories